Sep 2026· Advances in Materials· pp.
e74928
· 0 citations· 56 references
Medicine
TL;DR
It is demonstrated that the integration of natural bioactivity with supramolecular engineering provides a biocompatible strategy for coordinated tumor-bacterial disruption and immunogenic remodeling of the F. nucleatum-associated tumor niche in CRC.
Abstract
The intratumoral microbiota acts as a microbial immune checkpoint in colorectal cancer (CRC), yet current strategies either kill silently without immune activation or permit bacterial rebound through incomplete targeting. Here we report a bio-hybrid assembly designed to synchronize the eradication of CRC cells and their tumor-associated Fusobacterium nucleatum. This system integrates a hemoglobin (Hb)-augmented aggregation-induced emission (AIE) photosensitizing module into cRGD-functionalized ginger-derived vesicles. This architecture couples Hb-associated oxygen availability with molecular confinement of the photosensitizer while harnessing the intrinsic anti-inflammatory components of the plant carrier to mitigate off-target toxicity. Light activation initiates a dual cascade: it induces lysosomal pyroptosis in malignant cells and disrupts key F. nucleatum pathways related to membrane transport and DNA repair. This synchronized killing elicits the coordinated release of damage- and pathogen-associated molecular patterns (PAMPs), effectively transforming an immunologically cold tumor into a robust in situ vaccine that drives dendritic cell maturation and systemic T-cell immunity. Our findings demonstrate that the integration of natural bioactivity with supramolecular engineering provides a biocompatible strategy for coordinated tumor-bacterial disruption and immunogenic remodeling of the F. nucleatum-associated tumor niche in CRC.
Through this orchestrated modulation, MOF-808-Ro-G/N effectively remodels the TME into an immunologically "hot" niche, promoting robust cytotoxic T lymphocyte infiltration and achieving substantial tumor growth suppression.
In situ cancer vaccines exhibit promising therapeutic potential; however, their efficacy is constrained by limited antigen release, suboptimal spatiotemporal immune coordination, and adaptive immune resistance. In this study, we identify zinc ions (Zn2+) as synergistic agents with chemotherapeutics in modulating PANopt...
This findings demonstrate that E-R@ISSL achieved coordinated DNA damage, ferroptosis, and ICD induction through its dual-targeted and sequentially activated co-delivery of ETP and LA, concurrently dismantling the GSH/GPX4 antioxidant defense and intensifying oxidative injury.
Yan Wang, Chao-Zheng Zhang, Chen Sun et al.· Theranostics· 0 citations
Colorectal cancer (CRC) patients with microsatellite-stable tumors typically resist immune checkpoint blockade (ICB) due to an immunosuppressive "cold" microenvironment. Photodynamic therapy (PDT) generates reactive oxygen species (ROS) to ablate tumor cells and induce immunogenic cell death (ICD), potentiating antitum...
Current cancer phototherapy is often hindered by suboptimal immunogenicity and inevitable immune escape. Herein, a programmable bio-hybridized phototherapeutic platform is developed by chemical grafting drug-loaded phototherapeutic nano-modules on natural facultative anaerobic probiotics. Exploiting the innate hypoxi...
Daokuan An, Xiaocheng Wu, Yun-Sheng Shang et al.· National Science Review· 0 citations
A spatiotemporally regulated organelle-targeted nanoplatform, IR820-GEM@MIL101 (IGM), is developed, providing a promising strategy for light-regulated combinatorial immunotherapy against aggressive malignancies.
Pan Zhang, Ming-Lun Liu, Lei Huang et al.· Materials Today Bio· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.